MAP2K7 and melanoma: In melanoma cell lines, which have acquired resistance to the RAF inhibitor, elevated CRAF protein levels accounted for the acquisition of resistance to RAF inhibitor, and CRAF, but not BRAF activated the MEK/ERK pathway [38].